HUNTSVILLE, Ala.–(BUSINESS WIRE)–ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation networking solutions, announced today…
Operating over 170,000 owned and colocated ASICs servers in the Company’s data centers Produced over…
LITTLE ROCK, Ark.–(BUSINESS WIRE)–Windstream Wholesale, a leading provider of advanced optical solutions, with its first…
CHICAGO–(BUSINESS WIRE)–Victory Park Capital (“VPC”), a leading global alternative investment firm, today announced the additions…
HALIFAX, Nova Scotia & BRISBANE, Australia–(BUSINESS WIRE)–Today Emera Technologies Limited, a subsidiary of Emera Inc….
SeedPod Cyber Rewards channel partners using Augmentt Discover and Augmentt Secure to improve security posture…
Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating…
Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ET NEW YORK, NY,…
— Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12…
Study’s primary endpoint and key secondary endpoints were met Study found event-free survival and overall…
WARREN, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
— Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin —…
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Xalud Therapeutics, a clinical-stage biotechnology company developing…
Judy Chou, Ph.D. President and CEO SAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) — AltruBio…
REDWOOD CITY, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR), a…
Company expands its partnerships with leading patient advocacy groups to improve NASH education and patient…
Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and…
NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Preliminary data from the Phase 1/2 trial of PORT-2 demonstrates favorable safety and tolerability as…
SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…